ASH25: CAR-T Leaders Gilead, J&J Show in Multiple Myeloma; Fulcrum Rises on Sickle Cell Data

By /

The 2025 meeting of the American Society of Hematology features some of the newest developments in blood cancers and rare diseases.

Scroll to Top